Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.

Mohammad S Hossain, PhD, Wayne A Harris, Sarah W Myers, Mojtaba Akhtari, MD, Amelia A Langston, MD, Edmund K. Waller, MD, PhD

Blood (2009) 114 (22): 1165.

https://doi.org/10.1182/blood.V114.22.1165.1165

Published: 2009

Journal Articles

Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD.

Mohammad S Hossain, PhD, Andrew T Gewirtz, Ph.D., John D Roback, MD., Ph.D., Edmund K. Waller, MD, PhD

Blood (2009) 114 (22): 3561.

https://doi.org/10.1182/blood.V114.22.3561.3561

Published: 2009

Journal Articles

Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.

Mohammad S. Hossain, PhD, Ned Waller, MD. Ph.D

Blood (2007) 110 (11): 3270.

https://doi.org/10.1182/blood.V110.11.3270.3270

Published: 2007

Journal Articles

Homeostatic Expansion of Donor FoxP3+ CD25+CD4+ T Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft.

Mohammad S. Hossain, PhD, Cynthia R. Giver, Ph.D, Ned Waller, MD.,Ph.D

Blood (2006) 108 (11): 3207.

https://doi.org/10.1182/blood.V108.11.3207.3207

Published: 2006

Journal Articles

Host and Donor Immune Responses Contribute to Anti-Viral Effects of Amotosalen-Treated Donor Lymphocytes Following Early Post-Transplant CMV Infection.

Mohammad S. Hossain, PhD, John D. Roback, MD.Ph.D, Ned Waller, MD.Ph.D

Blood (2006) 108 (11): 3217.

https://doi.org/10.1182/blood.V108.11.3217.3217

Published: 2006

Journal Articles

Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation.

Mohammad S. Hossain, PhD, John D. Robak, MD, Ph.D, Edmund K. Waller, MD, Ph.D

Blood (2005) 106 (11): 3024.

https://doi.org/10.1182/blood.V106.11.3024.3024

Published: 2005

NARROW

Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.

Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD.

Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.

Homeostatic Expansion of Donor FoxP3+ CD25+CD4+ T Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft.

Host and Donor Immune Responses Contribute to Anti-Viral Effects of Amotosalen-Treated Donor Lymphocytes Following Early Post-Transplant CMV Infection.

Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Anti-Viral Immunity to CMV Reactivation in Allogeneic HSCT Recipients.

Prophylactic Use of Flagellin: A Novel Method to Boost Immune Reconstitution in Allogeneic HSCT Recipients with Limited GvHD.

Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.

Homeostatic Expansion of Donor FoxP3+ CD25+CD4+ T Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft.

Host and Donor Immune Responses Contribute to Anti-Viral Effects of Amotosalen-Treated Donor Lymphocytes Following Early Post-Transplant CMV Infection.

Prophylactic Amotosalen-Treated Donor T-Cells Prevent Late CMV Infection in Allogeneic Bone Marrow Transplantation.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only